Alembic Ltd - Stock Valuation and Financial Performance

BSE: 506235 | NSE: ALEMBICLTD | Pharmaceuticals & Drugs | Small Cap

Alembic Share Price

139.50 -5.95 -4.09%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Alembic

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Alembic stock performance -

mw4me loader
P/E Ratio (CD):
11.54
Market Cap:
3,582.1 Cr.
52-wk low:
78.2
52-wk high:
169

Is Alembic Ltd an attractive stock to invest in?

1. Is Alembic Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Alembic Ltd is a below average quality company.

2. Is Alembic Ltd undervalued or overvalued?

The key valuation ratios of Alembic Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Alembic Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Alembic Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Alembic:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Alembic Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 3.8%3.8%3.1%4.4%3.9%7.1%0.9%4.1%3.8%4.9%-
Value Creation
Index
-0.7-0.7-0.8-0.7-0.7-0.5-0.9-0.7-0.7-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 14412814712512473.973.578.2127157192
Sales YoY Gr.--11.4%15.4%-14.9%-1.2%-40.3%-0.6%6.4%62.7%23.8%-
Adj EPS 48.85.55.98.312.813.28.57.710.412.1
YoY Gr.-120.3%-37%5.6%41.2%54.5%3.5%-35.3%-10.4%36.3%-
BVPS (₹) 19.830.134.140.747.155.289.597.280.985.187.5
Adj Net
Profit
106235148156212328339219196268310
Cash Flow from Ops. 229.751.623.621.56.5-2.2-17.838.922.7-
Debt/CF from Ops. 000000-0.1000.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 1%4.9%28.9%23.8%
Adj EPS 11.3%4.8%-7.6%36.3%
BVPS17.6%12.6%-1.6%5.2%
Share Price 13.5% 20.1% 12.2% 51.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
24.635.317.315.618.524.918.39.28.612.614
Op. Profit
Mgn %
64.74.68.814.64.314.217.831.736.139.5
Net Profit
Mgn %
16.719.520.527.832.4123.713.6106.767.958.5161.7
Debt to
Equity
00000000000
Working Cap
Days
945404248217175258336488370359148
Cash Conv.
Cycle
3642591681318211018427722716651

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 14.00%

Sales growth is growing at healthy rate in last 3 years 28.91%

Sales growth is good in last 4 quarters at 40.58%

Net Profit has been subdued in last 3 years -7.55%

Latest Financials - Alembic Ltd.

Standalone Consolidated
TTM EPS (₹) 4.9 12.1
TTM Sales (₹ Cr.) 186 192
BVPS (₹.) 33 87.5
Reserves (₹ Cr.) 851 2,195
P/BV 4.22 1.59
PE 28.56 11.54
From the Market
52 Week Low / High (₹) 78.20 / 169.00
All Time Low / High (₹) 0.68 / 169.00
Market Cap (₹ Cr.) 3,582
Equity (₹ Cr.) 51.4
Face Value (₹) 2
Industry PE 44.3

Management X-Ray of Alembic:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Alembic

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales144128147125124747478127157
Operating Expenses 13512214011410671636487101
Manufacturing Costs251913792668912
Material Costs74709679671222234149
Employee Cost 27242320212123212423
Other Costs 9999101112121317
Operating Profit 9671117310144057
Operating Profit Margin (%) 6.0%4.7%4.6%8.8%14.0%4.2%14.2%17.8%31.7%36.1%
Other Income 22293137309411896455
Interest 1000000001
Depreciation 6654334578
Exceptional Items 0-3-600000-110
Profit Before Tax 232527444593179887103
Tax -11-1240312610
Profit After Tax 24252742419314868193
PAT Margin (%) 16.8%19.4%18.7%33.3%33.2%125.8%18.8%110.2%63.4%59.0%
Adjusted EPS (₹)4.08.85.46.18.312.813.48.77.410.5
Dividend Payout Ratio (%)4%2%4%3%2%5%2%21%30%23%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 5288039111,0861,2091,4182,2972,4972,0782,186
Share Capital 53535353515151515151
Reserves 4747508581,0321,1571,3672,2462,4452,0272,134
Minority Interest0000000000
Debt0000000007
Long Term Debt0000000007
Short Term Debt0000000000
Trade Payables19161516251318191731
Others Liabilities 101566657334094116115111
Total Liabilities 6488759921,1591,2661,4712,4092,6322,2102,335

Fixed Assets

Gross Block402372158144145145150151151152
Accumulated Depreciation2332251112131516181921
Net Fixed Assets169146148132131131134134132131
CWIP 20032221937001
Investments 2995897329131,0011,1332,0472,2081,7541,786
Inventories84755132353554878993
Trade Receivables4828222514914152320
Cash Equivalents 32212597222
Others Assets423538246086116186211302
Total Assets 6488759921,1591,2661,4712,4092,6322,2102,335

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 22105224227-2-183923
PBT 232527444593179887103
Adjustment -12-17-21-29-21-862-79-53-42
Changes in Working Capital 102461221-19-2811-38
Tax Paid 1-10-4-5-2-2-9-71
Cash Flow From Investing Activity 5-5-47-227257-3519726
Capex 01-14-9-23-22-47-34-25-56
Net Investments -14-28-59-3871-1011-27-2634
Others 1922262524881805848
Cash Flow From Financing Activity -25-5-5-3-92-6-15-6-46-48
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 2002000009
Interest Paid -100000000-1
Dividend Paid -5-5-5-5-6-6-15-5-46-56
Others -22000-8500000
Net Cash Flow 200-1157-52-500
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)5.583.713.214.183.587.080.753.63.524.36
ROCE (%)3.823.823.124.443.917.120.944.13.824.86
Asset Turnover Ratio0.180.180.160.120.10.050.040.030.050.07
PAT to CFO Conversion(x)0.920.41.930.570.540.08-0.14-0.210.480.25
Working Capital Days
Receivable Days2941035967575657685550
Inventory Days402217150119100175223329252210
Payable Days534935972112566253299163180

Alembic Ltd Stock News

Alembic Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Alembic on 20-Dec-2024 16:59 is ₹139.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Alembic stood at ₹3,582.1.
The latest P/E ratio of Alembic as of 20-Dec-2024 16:59 is 28.56.
The latest P/B ratio of Alembic as of 20-Dec-2024 16:59 is 4.22.
The 52-week high of Alembic is ₹169.0 and the 52-week low is ₹78.20.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alembic is ₹185.6 ( Cr.) .

About Alembic Ltd

Alembic is a Public Limited Company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised stock exchanges in India. The registered office of the Company is located at Alembic Road, Vadodara, Gujarat. The Company is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

Business area of the company

The company is primarily engaged in two businesses i.e.

API Manufacturing

  • Estolate
  • Biphenyl Valine Oxalate
  • Venlafaxine

Real Estate

  • Residential Projects
  • Commercial Project
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.